A patent triumph of public interest

New flexibilities make public interest safeguards integral to drug patent rights

Strong medicine for weak drug patents

Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend

Testing the CL route

Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs

Hepatitis C medication remains beyond reach

Price control may ensure patients complete their course of medication

Pharma’s dirty deals to stall generics

As generic companies, including Indian firms, collude with innovator pharma giants in pay-for-delay pacts, consumers pay a high price

A mysterious ring on a dwarf planet is puzzling astronomers

Quaoar, which revolves the Sun beyond Neptune, has a ring that is too far out according to current theories